BioSpace News Archive

Pharm Country

Bovine Respiratory Disease Treatment Market: Rising Demand for High Quality Bovine Derived Products is Influencing the Global Market

The demand within the global market for bovine respiratory disease treatment has been rising on account of advancements in the field of pulmonary disease treatment, finds TMR.

March 20, 2020
·
4 min read
Pharm Country

Breast Cancer Therapeutics Market: Rising Prevalence of Obesity and Diagnostic Screening Programs to Drive Market

As per a recent report by Transparency Market Research pertaining to global breast cancer therapeutics market states that the market is projected to grow substantially in from 2016 to 2024.

March 20, 2020
·
3 min read
Gastrointestinal Drugs Market: Increasing Levels of Stress, Changing Lifestyles, and Unhealthy Eating Habits to Drive Market

A report by Transparency Market Research states that the global gastrointestinal drugs market is expected to witness a robust growth during the tenure of 2016 to 2024.

March 20, 2020
·
3 min read
U. S. Bacterial Conjunctivitis Drugs Market: Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth

The bacterial conjunctivitis drug market in U.S. is extremely fragmented in nature as various players are operating in the market.

March 20, 2020
·
4 min read
Policy

Eli Lilly Partners with State of Indiana to Accelerate COVID-19 Testing

As the number of diagnosed cases of COVID-19 continues to rise in the United States, Eli Lilly has partnered with the Indiana State Department of Health to accelerate testing for the virus in that state.

March 20, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Industry News for March 20: Update on the Novel Coronavirus

A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.

March 20, 2020
·
5 min read
·
BioSpace Editorial Staff
Deals

China’s InnoCare Pharma Raises $289 Million in IPO

The company has nine drug candidates in human clinical trials.

March 20, 2020
·
2 min read
·
Mark Terry
Policy

BARDA: Athersys’ Cell Therapy “Highly Relevant” for COVID-19

“What we have could be a very powerful weapon against these types of viral outbreaks or pandemics because it isn’t pathogen- or virus-specific and could be broadly relevant in these types of situations,” Gil Van Bokkelen, Ph.D., Athersys CEO, told BioSpace.

March 20, 2020
·
4 min read
·
Gail Dutton
Biotech Bay

Bay Area Biopharma Company Drugs Lead the Way in COVID-19

As the world and biopharma grapple with developing vaccines and drugs against COVID-19, researchers are turning to a handful of drugs that show particular promise. Several of those drugs are by companies with offices or headquarters in the San Francisco Bay Area. Here’s a look.

March 20, 2020
·
2 min read
·
Mark Terry
BioCapital

Clinical Catch-Up: March 16-20

Here’s a look at some of last week’s clinical trial news.

March 20, 2020
·
7 min read
·
Mark Terry